Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1572 of 6351
-
New drug aims to shield cancer patients from chemo side effects
Disease control Not yet recruitingEvaluate the efficacy and safety of Trilaciclib for myeloprotection prior to chemotherapy in advanced cholangiocarcinoma or pancreatic cancer.
Phase 2 • Sponsor: The Second Affiliated Hospital of Shandong First Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:31 UTC
-
AR goggles join the fight against PTSD in veterans
Symptom relief Recruiting nowThe goal of this trial is to test how augmented reality exposure therapy (ARET) may potentiate the effects of traditional exposure therapy administered to U.S. military personnel diagnosed with PTSD. 40 adult males and females over the age of 18 that have served, or are currently…
Sponsor: Wayne State University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Painting and clay may boost brain and hand function in Alzheimer's patients
Symptom relief Not yet recruitingThis randomized controlled trial aims to investigate the effects of art therapy on cognitive functions and hand functions in individuals with Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder characterized by decline in memory, executive functio…
Sponsor: Fenerbahce University • Aim: Symptom relief
Last updated Jun 26, 2026 15:03 UTC
-
Could cooling the body save hearts after a massive attack?
Disease control Not yet recruitingThis study is a randomized controlled trial conducted at Beijing Anzhen Hospital, Capital Medical University. The primary objective is to assess the efficacy of mild therapeutic hypothermia in reducing infarct size and improving cardiac function in patients receiving percutaneous…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New immunotherapy combo aims to fight advanced kidney cancer
Disease control Not yet recruitingIntroduction: This document explains a clinical research study conducted at Peking Union Medical College Hospital. The study aims to evaluate a new combination treatment - Envafolimab (an immunotherapy) and Axitinib (a targeted therapy) - for patients newly diagnosed with advanc…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:32 UTC
-
New injection aims to tame kidney disease
Disease control Not yet recruitingThis study is divided into two parts (Part A and Part B). This study aims to evaluate the safety and efficacy of CM313 in subjects with primary Immunoglobulin A nephropathy(IgAN), while also observing its Pharmacokinetics(PK) characteristics, Pharmacokinetics(PD) effects, and imm…
Phase 2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:51 UTC
-
Could a Plant-Based diet keep your brain and muscles young?
Knowledge-focused Recruiting nowThis prospective study investigates the health effects of vegetarian and plant-based diets in middle-aged and older adults in Taiwan, specifically, recruiting 5000 Tzu Chi volunteers. Previous Tzu Chi cohorts found vegetarian diets were protectively associated with incidences of …
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis is an investigator-initiated trial to evaluate the efficacy and safety of BCMA/CD70-targeted CAR-T in the treatment of refractory pediatric rheumatic diseases.
Phase 1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
New psoriasis pill enters Mid-Stage trial
Disease control Not yet recruitingThe primary objective of this study is to evaluate the efficacy of multiple-dose HSK47388 versus placebo in participants with moderate-to-severe plaque psoriasis.
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:49 UTC
-
New hope for liver cancer: drug targets tumors resistant to immunotherapy
Disease control Not yet recruiting1. To investigate the efficacy and safety of cabozantinib in patients with progressive HCC after ICI-based combination treatment. 2. To explore potential tissue and peripheral blood biomarkers associated with clinical benefits of cabozantinib, and resistance mechanisms of prior I…
Phase 2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 26, 2026 12:37 UTC
-
New hope for rare blood disorder: linprixel trial launches
Disease control Not yet recruitingwAIHA or EVANS syndrome: Linpriril 40mg, oral, once daily. The therapeutic effect will be evaluated after 4 weeks. If the therapeutic effect does not reach the PR, the dose will be increased to 60mg once a day. After continuing to take it for 4 weeks, the therapeutic effect will …
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:46 UTC
-
Cheaper keytruda copycat tested in lung cancer patients
Disease control Not yet recruitingThe primary purpose of this study is to demonstrate Pharmacokinetic similarity in exposure after the initial dose and at steady state of QL2107 compared with Keytruda.
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:56 UTC
-
Tiny needle, big hope: new eye surgery trial for sudden blindness
Disease control Recruiting nowThis prospective interventional study evaluates the efficacy and safety of direct intra-arterial microneedle injection combined with pars plana vitrectomy for acute retinal artery occlusion (including central retinal artery occlusion \[CRAO\] and branch retinal artery occlusion \…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 12:38 UTC
-
New drug shows promise for rectal cancer patients
Disease control Recruiting nowThis is an observational, retrospective-prospective, multicentre trial enrolling all patients included in the AIFA monitoring registry of Dostarlimab for the indication in rectal cancer. The aims of the study are to describe the clinical outcomes and safety of patients with dMMR/…
Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Blood test may replace biopsies for bile duct cancer patients
Knowledge-focused Recruiting nowBiliary tract cancer (BTC) is a rare and heterogeneous disease with high incidence and mortality in Korea. Molecular profiling has enabled the identification of actionable alterations such as Isocitrate Dehydrogenase 1 (IDH1) mutations, FGFR2 fusions, ERBB2 amplifications, and dM…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Can a new type of therapy help people with PTSD?
Symptom relief Recruiting nowThis study is a longitudinal, multicenter, single-blind, two-arm randomized controlled trial designed to evaluate the effectiveness of Multi-Modal Cognitive Processing Therapy (MMCPT) for individuals with posttraumatic stress disorder (PTSD). Participants will be randomly assigne…
Sponsor: Far Eastern Memorial Hospital • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Exercise eases PTSD and improves sleep in quake survivors, study finds
Symptom relief CompletedThis randomized controlled trial aims to examine the effects of a moderate-intensity aerobic exercise program on post-traumatic stress disorder (PTSD) symptoms and sleep quality among earthquake survivors living in temporary accommodation centers. Participants are randomly assign…
Sponsor: Malatya Turgut Ozal University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can knowing frontal sinus anatomy make surgery safer?
Knowledge-focused CompletedIntroduction The frontal recess is a narrow and anatomically variable region that forms the frontal sinus drainage pathway. Variations in its anatomy, particularly those related to the agger nasi cell and other frontal recess cells, can impair frontal sinus drainage and contribu…
Sponsor: Al-Azhar University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Which dental onlay lasts longest after root canal? a Head-to-Head test
Disease control OngoingThis study aims to evaluate the survival rates of onlays placed over posterior endodontically treated teeth restored with zirconia, lithium disilicate and lithium disilicate reinforced with zirconia. Additionally, it seeks to identify and assess the failure modes associated with …
Sponsor: Yousef Mahmoud Salem • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a 'Teach-Back' approach boost confidence and ease anxiety after ostomy surgery?
Symptom relief Recruiting nowThe aim of this study is to examine the effect of ostomy care education-delivered to patients who have undergone ostomy surgery using the Teach-back method on patients' self-care ability, ostomy compliance, and anxiety levels.
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC